NCT03261102View on ClinicalTrials.gov

TDM Guided Early Optimization of ADAL in Crohn's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

January 15, 2025

Study Completion Date

June 1, 2025

Conditions
Crohn DiseaseDrug MonitoringInflammatory Bowel Diseases
Interventions
BIOLOGICAL

Adalimumab

Trial Locations (6)

T2N 4Z6

University of Calgary Medical Center (UCMC), Calgary

V6Z 1Y6

The University of British Columbia, Vancouver

N6A 5A5

London Health Sciences Centre (LHSC) University Hospital, London

K1H 8L6

The Ottawa Hospital, IBD Centre of Excellence, Ottawa

H3G 1A4

McGill University Hospital Center (MUHC), Montreal

J1G 2E8

Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

waqqas.afif

OTHER